News | October 22, 2025
ACG to invest $200 million in US hard-shell capsule manufacturing
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
Medico Remedies receives order worth US$ 1,781,000
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Subscribe To Our Newsletter & Stay Updated
